Kolexia
Bouaoud Jebrane
Chirurgie maxillo-faciale
Hôpital Pitie Salpetriere
Paris, France
73 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de la tête et du cou Carcinome épidermoïde Carcinomes Carcinome épidermoïde de la tête et du cou Marges d'exérèse Tumeurs de la bouche Sarcomes Tumeurs cutanées Récidive tumorale locale

Industries

{{person.topindus1.name}}
{{person.topindus1.tot}} collaboration(s)
Dernière en {{person.topindus1.last}}
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Extensive head and neck skin cancers: Carcinologic surgery as a cornerstone of treatment.
Journal of stomatology, oral and maxillofacial surgery   12 décembre 2023
Epidemiology of facial skin cancers managed in a French ambulatory surgical center.
Journal of stomatology, oral and maxillofacial surgery   04 décembre 2023
Abstract 4530: Single-cell analysis of oral squamous cell carcinoma (OSCC) from smoker vs. non-smoker patients highlights two groups of tumors with distinct immune microenvironments
Proceedings: AACR Annual Meeting 2023   01 avril 2023
From precise surgery to precision surgery: The multiple dimensions of therapeutic precision for head and neck cancer.
Journal of stomatology, oral and maxillofacial surgery   22 novembre 2022
Datasets for gene expression profiles of head and neck squamous cell carcinoma and lung cancer treated or not by PD1/PD-L1 inhibitors.
Data in brief   27 août 2022
Immunologically active phenotype by gene expression profiling is associated with clinical benefit from PD-1/PD-L1 inhibitors in real-world head and neck and lung cancer patients.
European journal of cancer (Oxford, England : 1990)   26 août 2022
Biomarkers of radioresistance in head and neck squamous cell carcinomas.
International journal of radiation biology   15 août 2022
Teaching how to break bad news in Oncology: In-class vs. virtual peer role-plays.
Bulletin du cancer   04 mai 2022
MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer.
Journal for immunotherapy of cancer   05 avril 2022
Unmet Needs and Perspectives in Oral Cancer Prevention.
Cancers   02 avril 2022